O'Dorisio T - Search Results

1

Neuroendocrine tumors: current recommendations for diagnosis and surgical management.

Joseph S, Wang YZ, Boudreaux JP, Anthony LB, Campeau R, Raines D, O'Dorisio T, Go VL, Vinik AI, Cundiff J, Woltering EA. Joseph S, et al. Endocrinol Metab Clin North Am. 2011 Mar;40(1):205-31, x. doi: 10.1016/j.ecl.2010.08.004. Endocrinol Metab Clin North Am. 2011. PMID: 21349420 Review.

2

Neuroendocrine tumors: a critical appraisal of management strategies.

Vinik AI, Anthony L, Boudreaux JP, Go VL, O'Dorisio TM, Ruszniewski P, Woltering EA. Vinik AI, et al. Pancreas. 2010 Aug;39(6):801-18. doi: 10.1097/MPA.0b013e3181ea5839. Pancreas. 2010. PMID: 20664478

3

NANETS consensus guidelines for the diagnosis of neuroendocrine tumor.

Vinik AI, Woltering EA, Warner RR, Caplin M, O'Dorisio TM, Wiseman GA, Coppola D, Go VL; North American Neuroendocrine Tumor Society (NANETS). Vinik AI, et al. Pancreas. 2010 Aug;39(6):713-34. doi: 10.1097/MPA.0b013e3181ebaffd. Pancreas. 2010. PMID: 20664471 No abstract available.

4

The NANETS consensus guidelines for the diagnosis and management of gastrointestinal neuroendocrine tumors (nets): well-differentiated nets of the distal colon and rectum.

Anthony LB, Strosberg JR, Klimstra DS, Maples WJ, O'Dorisio TM, Warner RR, Wiseman GA, Benson AB 3rd, Pommier RF; North American Neuroendocrine Tumor Society (NANETS). Anthony LB, et al. Pancreas. 2010 Aug;39(6):767-74. doi: 10.1097/MPA.0b013e3181ec1261. Pancreas. 2010. PMID: 20664474

5

Effect of octreotide LAR dose and weight on octreotide blood levels in patients with neuroendocrine tumors.

Woltering EA, Mamikunian PM, Zietz S, Krutzik SR, Go VL, Vinik AI, Vinik E, O'Dorisio TM, Mamikunian G. Woltering EA, et al. Pancreas. 2005 Nov;31(4):392-400. doi: 10.1097/01.mpa.0000186249.89081.0d. Pancreas. 2005. PMID: 16258376

6

Validation of serum versus plasma measurements of chromogranin a levels in patients with carcinoid tumors: lack of correlation between absolute chromogranin a levels and symptom frequency.

Woltering EA, Hilton RS, Zolfoghary CM, Thomson J, Zietz S, Go VL, Vinik AI, Vinik E, O'Dorisio TM, Mamikunian G. Woltering EA, et al. Pancreas. 2006 Oct;33(3):250-4. doi: 10.1097/01.mpa.0000235302.73615.d4. Pancreas. 2006. PMID: 17003646

7

A prospective trial on the effect of body mass index and sex on plasma octreotide levels in patients undergoing long-term octreotide LAR therapy.

Joseph S, Li G, Lindholm E, Zhou Y, Go VL, Vinik AI, O'Dorisio TM, Mamikunian G, Woltering EA. Joseph S, et al. Pancreas. 2010 Oct;39(7):964-6. doi: 10.1097/MPA.0b013e3181db01a8. Pancreas. 2010. PMID: 20467346 Free PMC article.

8

A single fasting plasma 5-HIAA value correlates with 24-hour urinary 5-HIAA values and other biomarkers in midgut neuroendocrine tumors (NETs).

Tellez MR, Mamikunian G, O'Dorisio TM, Vinik AI, Woltering EA. Tellez MR, et al. Pancreas. 2013 Apr;42(3):405-10. doi: 10.1097/MPA.0b013e318271c0d5. Pancreas. 2013. PMID: 23160483

9

A 25-Year Experience of Gastroenteropancreatic Neuroendocrine Tumors and Somatostatin (Congeners) Analogs: From Symptom Control to Antineoplastic Therapy.

O'Dorisio TM, Anthony LB. O'Dorisio TM, et al. Front Horm Res. 2015;44:177-92. doi: 10.1159/000382146. Epub 2015 Aug 14. Front Horm Res. 2015. PMID: 26303712 Review.

10

Radioligand Theranostics in the Management of Neuroendocrine Tumors.

Harris AG, Vinik AI, OʼDorisio TM, OʼDorisio MS. Harris AG, et al. Pancreas. 2020 May/Jun;49(5):599-603. doi: 10.1097/MPA.0000000000001546. Pancreas. 2020. PMID: 32433395 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

351 results

Search Page

Filters